Model
Edge
4D Molecular Therapeutics
0001834021
Filing Type
4
Filing Date
6/22/2026
Updated
6/23/26, 2:19 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership